These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 32453342)

  • 1. Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia.
    Tuazon AMA; Lott P; Bohórquez M; Benavides J; Ramirez C; Criollo A; Estrada-Florez A; Mateus G; Velez A; Carmona J; Olaya J; Garcia E; Polanco-Echeverry G; Stultz J; Alvarez C; Tapia T; Ashton-Prolla P; ; Vega A; Lazaro C; Tornero E; Martinez-Bouzas C; Infante M; De La Hoya M; Diez O; Browning BL; ; Rannala B; Teixeira MR; Carvallo P; Echeverry M; Carvajal-Carmona LG
    Breast Cancer Res; 2020 Oct; 22(1):108. PubMed ID: 33087180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients.
    Grasel RS; Felicio PS; de Paula AE; Campacci N; Garcia FAO; de Andrade ES; Evangelista AF; Fernandes GC; Sabato CDS; De Marchi P; Souza CP; de Paula CAA; Torrezan GT; Galvão HCR; Carraro DM; Palmero EI
    Front Oncol; 2020; 10():571330. PubMed ID: 33134171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XAF1 as a modifier of p53 function and cancer susceptibility.
    Pinto EM; Figueiredo BC; Chen W; Galvao HCR; Formiga MN; Fragoso MCBV; Ashton-Prolla P; Ribeiro EMSF; Felix G; Costa TEB; Savage SA; Yeager M; Palmero EI; Volc S; Salvador H; Fuster-Soler JL; Lavarino C; Chantada G; Vaur D; Odone-Filho V; Brugières L; Else T; Stoffel EM; Maxwell KN; Achatz MI; Kowalski L; de Andrade KC; Pappo A; Letouze E; Latronico AC; Mendonca BB; Almeida MQ; Brondani VB; Bittar CM; Soares EWS; Mathias C; Ramos CRN; Machado M; Zhou W; Jones K; Vogt A; Klincha PP; Santiago KM; Komechen H; Paraizo MM; Parise IZS; Hamilton KV; Wang J; Rampersaud E; Clay MR; Murphy AJ; Lalli E; Nichols KE; Ribeiro RC; Rodriguez-Galindo C; Korbonits M; Zhang J; Thomas MG; Connelly JP; Pruett-Miller S; Diekmann Y; Neale G; Wu G; Zambetti GP
    Sci Adv; 2020 Jun; 6(26):eaba3231. PubMed ID: 32637605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario.
    de Freitas Ribeiro AA; Junior NMC; Dos Santos LL
    Eur J Med Res; 2024 Mar; 29(1):187. PubMed ID: 38504328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer.
    Richau CS; Scherer NM; Matta BP; de Armas EM; de Barros Moreira FC; Bergmann A; Pereira Chaves CB; Boroni M; Dos Santos ACE; Moreira MAM
    Cancer Med; 2024 Feb; 13(3):e6729. PubMed ID: 38308422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of High-Risk Mutations among Breast Cancer Patients Referred for Multigene Panel Testing in a Romanian Population.
    Goidescu IG; Nemeti G; Surcel M; Caracostea G; Florian AR; Cruciat G; Staicu A; Muresan D; Goidescu C; Pintican R; Eniu DT
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service.
    Matta BP; Gomes R; Mattos D; Olicio R; Nascimento CM; Ferreira GM; Brant AC; Boroni M; Furtado C; Lima V; Moreira MÂM; Dos Santos ACE
    Sci Rep; 2022 Nov; 12(1):18629. PubMed ID: 36329109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary Breast Cancer in the Brazilian State of Ceará (The CHANCE Cohort): Higher-Than-Expected Prevalence of Recurrent Germline Pathogenic Variants.
    Gifoni ACLVC; Gifoni MAC; Wotroba CM; Palmero EI; Costa ELV; Dos Santos W; Achatz MI
    Front Oncol; 2022; 12():932957. PubMed ID: 35957908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa.
    ElBiad O; Laraqui A; El Boukhrissi F; Mounjid C; Lamsisi M; Bajjou T; Elannaz H; Lahlou AI; Kouach J; Benchekroune K; Oukabli M; Chahdi H; Ennaji MM; Tanz R; Sbitti Y; Ichou M; Ennibi K; Badaoui B; Sekhsokh Y
    BMC Cancer; 2022 Feb; 22(1):208. PubMed ID: 35216584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African.
    Laraqui A; Uhrhammer N; Rhaffouli HE; Sekhsokh Y; Lahlou-Amine I; Bajjou T; Hilali F; El Baghdadi J; Al Bouzidi A; Bakri Y; Amzazi S; Bignon YJ
    Dis Markers; 2015; 2015():194293. PubMed ID: 25814778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haplotypic characterization of BRCA1 c.5266dupC, the prevailing mutation in Brazilian hereditary breast/ovarian cancer.
    Gomes R; Soares BL; Felicio PS; Michelli R; Netto CBO; Alemar B; Ashton-Prolla P; Palmero EI; Moreira MÂM
    Genet Mol Biol; 2020; 43(2):e20190072. PubMed ID: 32453342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
    Fernandes GC; Michelli RA; Galvão HC; Paula AE; Pereira R; Andrade CE; Felicio PS; Souza CP; Mendes DR; Volc S; Berardinelli GN; Grasel RS; Sabato CS; Viana DV; Mauad EC; Scapulatempo-Neto C; Arun B; Reis RM; Palmero EI
    Oncotarget; 2016 Dec; 7(49):80465-80481. PubMed ID: 27741520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations.
    Hamel N; Feng BJ; Foretova L; Stoppa-Lyonnet D; Narod SA; Imyanitov E; Sinilnikova O; Tihomirova L; Lubinski J; Gronwald J; Gorski B; Hansen Tv; Nielsen FC; Thomassen M; Yannoukakos D; Konstantopoulou I; Zajac V; Ciernikova S; Couch FJ; Greenwood CM; Goldgar DE; Foulkes WD
    Eur J Hum Genet; 2011 Mar; 19(3):300-6. PubMed ID: 21119707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
    Walsh T; Mandell JB; Norquist BM; Casadei S; Gulsuner S; Lee MK; King MC
    JAMA Oncol; 2017 Dec; 3(12):1647-1653. PubMed ID: 28727877
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.